secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2023-09-28T23:59:59+00:00
Accession:  0001493152-23-034618
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim shareholders approve 2M-share increase to 2019 equity plan
----------------------------------------------------------------

- Shareholders approved amendment to 2019 Equity Incentive Plan to add 2,000,000 authorized shares (21,214,229 for, 2,361,341 against).
- Total share reserve under the plan now 11,003,242, plus automatic annual evergreen increases through 2029.
- All five director nominees (Cassano, Liu, Mulica, Steenstra, Wang) elected at annual meeting.
- Plan amendment effective September 28, 2023; enables continued equity grants to employees, directors, and consultants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315223034618/0001493152-23-034618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315223034618/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer